(Q45054229)

9 December 2017

Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection (English)

1 reference

9 December 2017

0 references

neutrophil recruitment

1 reference

Wan C Tsai

1

1 reference

9 December 2017

Michael L Rodriguez

2

1 reference

9 December 2017

Katherine S Young

3

1 reference

9 December 2017

Jane C Deng

4

1 reference

9 December 2017

Victor J Thannickal

5

1 reference

9 December 2017

Kazuhiro Tateda

6

1 reference

9 December 2017

Marc B Hershenson

7

1 reference

9 December 2017

Theodore J Standiford

8

1 reference

9 December 2017

language of work or name

English

0 references

publication date

10 September 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

9 December 2017

1 reference

9 December 2017

170

1 reference

9 December 2017

1331-1339

1 reference

9 December 2017

12

1 reference

Effect of high-dose ibuprofen in patients with cystic fibrosis.

9 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Current understanding of the inflammatory process in cystic fibrosis: onset and etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Intravenous azithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Macrolides for the treatment of Pseudomonas aeruginosa infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Anti-inflammatory capabilities of macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Immunomodulation by antibacterial agents. Is it clinically relevant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Effects of dirithromycin and erythromycylamine on human neutrophil degranulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Anti-inflammatory effects of macrolides in lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Hsc/Hsp70 interacting protein (hip) associates with CXCR2 and regulates the receptor signaling and trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

CXCR2 regulation of tumor necrosis factor-alpha adherence-dependent peroxide production is significantly diminished after severe injury in human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Propofol inhibits FMLP-stimulated phosphorylation of p42 mitogen-activated protein kinase and chemotaxis in human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

A comparison of post-receptor signal transduction events in Jurkat cells transfected with either IL-8R1 or IL-8R2. Chemokine mediated activation of p42/p44 MAP-kinase (ERK-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Selective inhibition of interleukin-8-induced neutrophil chemotaxis by ketoprofen isomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Inhibition of IL-8-mediated MAPK activation in human neutrophils by beta1 integrin ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Molecular crosstalk between p70S6k and MAPK cell signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Azithromycin, the multidrug-resistant protein, and cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

Role of extracellular calcium in in vitro uptake and intraphagocytic location of macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200402-200OC

10.1164/RCCM.200402-200OC

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference